PharmCAT.NET

Biostatistics, pharmacokinetics and clinical trials.

  • Home page
  • Blog
  • Contacts
  • Agreement & Confidentiality

IBM SPSS Extension: R Project PowerTOST library

Posted on December 31, 2018December 31, 2018 by frozencat

IBM SPSS Extension PowerTOST R Project library. Syntax command: POWERTOST.

Version: 1.0.0

Functions:

  • power.TOST
  • sampleN.TOST
  • CVfromCI

Дизайны:

  • parallel
  • 2×2
  • 2x2x4

Скачать/Download

GitHUB: https://github.com/PharmCat/SPSSPowerTOST

Categories: Blog, SPSS

Post navigation

Next Post:

Recent Posts

  • IBM SPSS + R Project: Confidence intervals for proportions, independent groups
  • IBM SPSS Extension: R Project PowerTOST library

Галерея

IMG-20170807-WA0013
20180131 165519
20180202 161523
20170729 203821
20170731 191623
20180814 193101
  • CDER Program for the Recognition of Voluntary Consensus Standards Related to Pharmaceutical Quality (CDER Quality Standards Program)
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Medication Health Fraud
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • FDA and Kratom
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Hiding in Plain Sight: 7-OH Products
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • FDA warns about heavy metal poisoning associated with certain unapproved ayurvedic drug products
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Certain bodybuilding products put consumers at risk for heart attack, stroke, serious liver damage and more
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Fraudulent Products
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-03 By FDA
  • Public Meeting on the Reauthorization of the Biosimilar User Fee Act (BsUFA) - 12/03/2025
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-12-02 By FDA
  • Recently Issued Guidance Documents
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-02 By FDA
  • Labeling and Promotion Guidances
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-12-02 By FDA
  • Bioresearch Monitoring Information System (BMIS)
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-12-02 By FDA
  • FDA Grand Rounds – Advancing Real-World Evidence in FDA Regulatory Decision Making - 12/11/2025
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2025-12-02 By FDA
  • Human medicines European public assessment report (EPAR): Kaletra, lopinavir,ritonavir, Date of authorisation: 19/03/2001, Revision: 65, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-12-02
  • Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Date of authorisation: 19/06/2015, Revision: 23, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-12-02
  • Human medicines European public assessment report (EPAR): Izamby, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-12-02
Older posts
Theme: Scaffold by Danny Cooper.